Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

The study explored a possible link between finasteride use and suicide.

Sapium rotundifolium extract may help treat enlarged prostate.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Low doses of Coffea arabica seed extract prevent prostate growth and lower uric acid and PSA levels.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

Finasteride may reduce prostate tumor cell invasion and spread.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Taking finasteride for over a month before surgery reduces blood loss during TURP.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Early balding may be a sign of future prostate problems.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.